ZOPIMAX

This brand name is authorized in Nigeria.

Active ingredients

The drug ZOPIMAX contains one active pharmaceutical ingredient (API):

1	Zopiclone UNII 03A5ORL08Q - ZOPICLONE
	Zopiclone is a hypnotic agent belonging to the cyclopyrrolone class of psychotherapeutic agents. It rapidly initiates and sustains sleep without reduction of total REM sleep and with preservation of slow wave sleep. Negligible residual effects are seen the following morning. Its pharmacological properties include hypnotic, sedative, anxiolytic, anticonvulsant and muscle-relaxant actions.
	Read more about Zopiclone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3135	Tablet	Zopimax Tablets TAB 5 mg		21/12/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CF01	Zopiclone	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CF Benzodiazepine related drugs
Discover more medicines within N05CF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3135